Figure 8.
Most significant pathway and key genes (marked in red) among the proliferative diabetic retinopathy treatment targets of the compound Xueshuantong capsule and Hexuemingmu tablet.
Most significant pathway and key genes (marked in red) among the proliferative diabetic retinopathy treatment targets of the compound Xueshuantong capsule and Hexuemingmu tablet.